|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rigel DS, Friedman RJ and Kopf AW:
Lifetime risk for development of skin cancer in the U.S.
population: Current estimate is now 1 in 5. J Am Acad Dermatol.
35:1012–1013. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Szeimies RM and Karrer S: Towards a more
specific therapy: Targeting nonmelanoma skin cancer cells. Br J
Dermatol. 154 (Suppl 1):16–21. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Holterhues C, Vries E, Louwman MW,
Koljenović S and Nijsten T: Incidence and trends of cutaneous
malignancies in the Netherlands, 1989–2005. J Invest Dermatol.
130:1807–1812. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Senerchia AA, Ribeiro KB and
Rodriguez-Galindo C: Trends in incidence of primary cutaneous
malignancies in children, adolescents, and young adults: A
population-based study. Pediatr Blood Cancer. 61:211–216. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Roewert-Huber J, Lange-Asschenfeldt B,
Stockfleth E and Kerl H: Epidemiology and aetiology of basal cell
carcinoma. Br J Dermatol. 157 (Suppl 2):47–51. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kurian RR, Di Palma S and Barrett AW:
Basal cell carcinoma metastatic to parotid gland. Head Neck Pathol.
8:349–353. 2014.PubMed/NCBI
|
|
8
|
Moser S, Borm J, Mihic-Probst D, Jacobsen
C and Kruse Gujer AL: Metastatic basal cell carcinoma: Report of a
case and review of the literature. Oral Surg Oral Med Oral Pathol
Oral Radiol. 117:e79–e82. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sleightholm RL, Willcockson JR, Watley DC,
Durden FL and Foster JM: Bilateral lymphatic spread of metastatic
basal cell carcinoma. Plast Reconstr Surg Glob Open. 4:e11822016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Athar M, Tang X, Lee JL, Kopelovich L and
Kim AL: Hedgehog signalling in skin development and cancer. Exp
Dermatol. 15:667–677. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hahn H, Wicking C, Zaphiropoulous PG,
Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E,
Unden AB, Gillies S, et al: Mutations of the human homolog of
Drosophila patched in the nevoid basal cell carcinoma syndrome.
Cell. 85:841–851. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Johnson RL, Rothman AL, Xie J, Goodrich
LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein EH Jr
and Scott MP: Human homolog of patched, a candidate gene for the
basal cell nevus syndrome. Science. 272:1668–1671. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stone DM, Hynes M, Armanini M, Swanson TA,
Gu Q, Johnson RL, Scott MP, Pennica D, Goddard A, Phillips H, et
al: The tumour-suppressor gene patched encodes a candidate receptor
for sonic hedgehog. Nature. 384:129–134. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fan H, Oro AE, Scott MP and Khavari PA:
Induction of basal cell carcinoma features in transgenic human skin
expressing sonic hedgehog. Nat Med. 3:788–792. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Oro AE, Higgins KM, Hu Z, Bonifas JM,
Epstein EH Jr and Scott MP: Basal cell carcinomas in mice
overexpressing sonic hedgehog. Science. 276:817–821. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xie J, Murone M, Luoh SM, Ryan A, Gu Q,
Zhang C, Bonifas JM, Lam CW, Hynes M, Goddard A, et al: Activating
smoothened mutations in sporadic basal-cell carcinoma. Nature.
391:90–92. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Grachtchouk M, Mo R, Yu S, Zhang X, Sasaki
H, Hui CC and Dlugosz AA: Basal cell carcinomas in mice
overexpressing Gli2 in skin. Nat Genet. 24:216–217. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nilsson M, Undèn AB, Krause D, Malmqwist
U, Raza K, Zaphiropoulos PG and Toftgård R: Induction of basal cell
carcinomas and trichoepitheliomas in mice overexpressing GLI-1.
Proc Natl Acad Sci USA. 97:3438–3443. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li C, Chi S and Xie J: Hedgehog signaling
in skin cancers. Cell Signal. 23:1235–1243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ponta H, Sherman L and Herrlich PA: CD44:
From adhesion molecules to signalling regulators. Nat Rev Mol Cell
Biol. 4:33–45. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zöller M: CD44: Can a cancer-initiating
cell profit from an abundantly expressed molecule? Nat Rev Cancer.
11:254–267. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cheng C and Sharp PA: Regulation of CD44
alternative splicing by SRm160 and its potential role in tumor cell
invasion. Mol Cell Biol. 26:362–370. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Formby B and Stern R: Phosphorylation
stabilizes alternatively spliced CD44 mRNA transcripts in breast
cancer cells: Inhibition by antisense complementary to casein
kinase II mRNA. Mol Cell Biochem. 187:23–31. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Weg-Remers S, Ponta H, Herrlich P and
König H: Regulation of alternative pre-mRNA splicing by the ERK
MAP-kinase pathway. EMBO J. 20:4194–4203. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dang H, Ding W, Emerson D and Rountree CB:
Snail1 induces epithelial-to-mesenchymal transition and tumor
initiating stem cell characteristics. BMC Cancer. 11:3962011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shuang ZY, Wu WC, Xu J, Lin G, Liu YC, Lao
XM, Zheng L and Li S: Transforming growth factor-β1-induced
epithelial-mesenchymal transition generates ALDH-positive cells
with stem cell properties in cholangiocarcinoma. Cancer Lett.
354:320–328. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rudzki Z and Jothy S: CD44 and the
adhesion of neoplastic cells. Mol Pathol. 50:57–71. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hu S, Wu X, Zhou B, Xu Z, Qin J, Lu H, Lv
L, Gao Y, Deng L, Yin J and Li G: IMP3 combined with CD44s, a novel
predictor for prognosis of patients with hepatocellular carcinoma.
J Cancer Res Clin Oncol. 140:883–893. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
So PL, Langston AW, Daniallinia N, Hebert
JL, Fujimoto MA, Khaimskiy Y, Aszterbaum M and Epstein EH Jr:
Long-term establishment, characterization and manipulation of cell
lines from mouse basal cell carcinoma tumors. Exp Dermatol.
15:742–750. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Patrawala L, Calhoun T,
Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra
D, Zhou J, Claypool K, et al: Highly purified CD44+ prostate cancer
cells from xenograft human tumors are enriched in tumorigenic and
metastatic progenitor cells. Oncogene. 25:1696–1708. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hooper JE and Scott MP: Communicating with
hedgehogs. Nat Rev Mol Cell Biol. 6:306–317. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wong SY, Seol AD, So PL, Ermilov AN,
Bichakjian CK, Epstein EH Jr, Dlugosz AA and Reiter JF: Primary
cilia can both mediate and suppress hedgehog pathway-dependent
tumorigenesis. Nat Med. 15:1055–1061. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Han YG, Kim HJ, Dlugosz AA, Ellison DW,
Gilbertson RJ and Alvarez-Buylla A: Dual and opposing roles of
primary cilia in medulloblastoma development. Nat Med.
15:1062–1065. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jang BI, Li Y, Graham DY and Cen P: The
role of CD44 in the pathogenesis, diagnosis, and therapy of gastric
cancer. Gut Liver. 5:397–405. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Okayama H, Kumamoto K, Saitou K, Hayase S,
Kofunato Y, Sato Y, Miyamoto K, Nakamura I, Ohki S, Sekikawa K and
Takenoshita S: CD44v6, MMP-7 and nuclear Cdx2 are significant
biomarkers for prediction of lymph node metastasis in primary
gastric cancer. Oncol Rep. 22:745–755. 2009.PubMed/NCBI
|
|
39
|
Tsuchida A, Nagakawa Y, Kasuya K, Matudo
T, Kyo B, Suzuki Y, Aoki T, Sato E, Nagao T and Itoi T:
Significance of CD44s and CD44v6 expression in pancreaticobiliary
maljunction. Hepatogastroenterology. 58:1877–1881. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Riabov V, Gudima A, Wang N, Mickley A,
Orekhov A and Kzhyshkowska J: Role of tumor associated macrophages
in tumor angiogenesis and lymphangiogenesis. Front Physiol.
5:752014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ingham PW and McMahon AP: Hedgehog
signaling in animal development: Paradigms and principles. Genes
Dev. 15:3059–3087. 2001. View Article : Google Scholar : PubMed/NCBI
|
